TABLE 1.
Clinical and biochemical characteristics, and immunosuppressive therapy of patients without CAV (CAV−), patients with CAV (CAV+), and of patients with end-stage native CAD
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.